# Measles Vaccination at Health System Contacts

> **NCT04220671** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Bandim Health Project** · enrollment: 5400 (estimated)

## Conditions studied

- Measles Vaccine
- Hospital Admission
- Mortality
- Non-specific (Heterologous) Effects of Vaccines

## Interventions

- **BIOLOGICAL:** measles vaccine
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT04220671
- **Lead sponsor:** Bandim Health Project
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2020-01-08
- **Primary completion:** 2026-12
- **Final completion:** 2027-06
- **Target enrollment:** 5400 (ESTIMATED)
- **Last updated:** 2025-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04220671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04220671, "Measles Vaccination at Health System Contacts". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04220671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*